WooGene B&G Co., Ltd

₩2,725As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:018620Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (18.49%)
Div yield 2.96%
ROE (5.16%)
Pharmaceutical Preparations
Beta (5Y) 0.18
PE TTM —
TSR TTM (25.26%)
Mkt cap ₩18.89B
ROIC 2.18%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,952
8.33%
(60.31%)
Hold 11|1|1|5|7
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
53.84
51.94
53.05
51.71
6.38%
7.47%
8.99%
(0.07%)
Revenue₩B
1.581
1.610
1.668
1.646
9.89%
14.20%
13.43%
9.69%
Peers (US$13.93M)
Cap (US$)
PE
14.50M
11.31x
14.32M
10.49x
Capital
TTM
5Y
10Y
Leveragex
1.934
0.400
0.284
EBIT/Intx
0.268
0.877
0.816
Own earn%
(62.45)
124.78
112.53
Sh yield%
15.59
61.63
61.64
Owners
Insiders/Inst%
4.74
52.13
Short interest%
5.90
SBC / revenue%
3.86
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
17–24
$1 testx
0.0
Incr. ROIC%
5